Click Therapeutics, Inc. develops, validates, and commercializes software as prescription medical treatments aimed at addressing unmet medical needs. As a leader in the field of Digital Therapeutics™, Click offers accessible and clinically proven FDA-regulated treatments that can be delivered directly to patients via their smartphones. The company's approach integrates rigorous scientific and technical standards with patient-centric design, creating engaging therapeutic experiences that yield significant clinical results. Click's innovative platform encompasses various cognitive, behavioral, and neuromodulatory mechanisms, harnessing advanced data-driven technologies like artificial intelligence and machine learning. The digital therapeutics in development target a range of therapeutic areas, including psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Committed to an inclusive and diverse workforce of professionals from multiple disciplines, Click Therapeutics strives to expand access to safe and effective treatments for patients everywhere.